Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States,

Mohamad Alkhouli1, Fahad Alqahtani2, Ankur Kalra3

  • 1Department of Cardiology, Mayo Clinic School of Medicine, Rochester, Minnesota.

JAMA Network Open
|February 15, 2020
PubMed

Insights

Contemporary trends show increasing risk factors in patients undergoing percutaneous coronary intervention (PCI) and coronary bypass grafting (CABG). While CABG mortality decreased, PCI mortality saw slight increases, highlighting evolving risk profiles and outcomes in cardiac revascularization.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Limited data exists on current risk profiles and outcomes for patients undergoing percutaneous coronary intervention (PCI) or coronary bypass grafting (CABG).
  • Understanding these trends is crucial for optimizing patient care and resource allocation in cardiovascular medicine.

Purpose of the Study:

  • To analyze contemporary trends in patient characteristics and outcomes for PCI and CABG in the United States.
  • To evaluate changes in risk factors, clinical presentation, and mortality rates over time for these revascularization procedures.

Main Methods:

  • Retrospective cohort study utilizing a national inpatient claims database (2003-2016).
  • Analysis of demographic characteristics, risk factors, clinical indications, and in-hospital mortality stratified by procedure (PCI vs. CABG) and era.
  • Risk-adjusted mortality analysis performed across three distinct time periods.

Main Results:

  • Over 12 million revascularization hospitalizations were identified, with PCI comprising 72% and CABG 28%.
  • Annual volumes for both PCI and CABG decreased, while patient populations showed increases in age, male sex, non-white race, lower income, and prevalence of risk factors.
  • Risk-adjusted mortality significantly decreased after CABG across all indications, but showed slight increases after PCI for specific conditions like STEMI and unstable angina.

Conclusions:

  • Significant shifts in patient demographics and risk profiles were observed for both PCI and CABG between 2003 and 2016.
  • Mortality following CABG improved significantly, whereas PCI outcomes showed mixed results with slight increases in mortality for certain indications.
  • These findings underscore the need for continued monitoring and adaptation of treatment strategies in cardiac revascularization.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
154
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
251
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
611
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
296